Results 201 to 210 of about 154,772 (354)

MAT2A promotes atherosclerotic plaque vulnerability by mediating epigenetic reprogramming of macrophages. [PDF]

Nat Commun
Du Z, Wan P, Du M, Li S, Yan Q, Sun S, Tang C, Jiang Z, Li S, Shi G, Miao B, Du X, Li S, Fang S, Wang C, Fang C, Yu B, Dai J, Sun P.   +18 more
europepmc   +1 more source

Ultrastructural changes in atherosclerotic plaques following the instillation of airborne particulate matter into the lungs of rabbits

, 2010
Erin M. Tranfield, Stephan F. van Eeden, Kazuhiro Yatera, James C. Hogg, David C. Walker   +4 more
openalex   +2 more sources

Tracking Monocyte Recruitment and Macrophage Accumulation in Atherosclerotic Plaque Progression Using a Novel hCD68GFP/ApoE ^−/− Reporter Mouse—Brief Report [PDF]

, 2016
Eileen McNeill, Asif Iqbal, Daniel Jones, Jyoti Patel, Patricia Coutinho, Lewis Taylor, David R. Greaves, Keith M. Channon   +7 more
openalex   +1 more source

The Impact of Methotrexate on Cardiovascular Outcomes in Psoriasis: A Systematic Review and Meta‐Analysis

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Psoriasis is a chronic immune‐mediated inflammatory disease with a global prevalence of 2%–3% and 1.3% in Brazil. It is associated with comorbidities such as obesity, hypertension, and diabetes, all of which contribute to increased cardiovascular risk due to systemic inflammation and endothelial dysfunction.
Tiago A. S. Costa, Sheila T. K. Medorima, Renata F. Magalhães   +2 more
wiley   +1 more source

The Role of the NF-κB Signaling Pathway in Atherosclerotic Plaque Rupture and Targeted Therapeutic Strategies. [PDF]

Biomedicines
Yin L, Wang X, Xiong N, Xiong J, Liu Q, Li H, Huang Y, Lv J, Wang Y, Wang Z.   +9 more
europepmc   +1 more source

MicroRNA-96 inhibition retarded the progression of atherosclerotic plaques via FOXO1/CYP7A1 mediated cholesterol-bile acid metabolism pathway

Li Wang, Yiting Liu, Jin Zhang, Jie Wu, Yue Li, Lifei Wang, Yang Zhang, Bin Hong   +7 more
openalex   +1 more source

Unravelling the Major Cardiovascular Risks of Systemic Psoriasis Medications: A Literature Systematic Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Psoriasis is a chronic inflammatory dermatological condition associated with an elevated risk of cardiovascular events (CVEs). Systemic therapies have transformed disease management, but their cardiovascular (CV) safety profiles remain incompletely understood and inconsistently reported.
Mai Thi Hoai Son, Yves Julien Mbama Biloa, Pauline Gouttefarde, Thomas Franck, Gilles Cizeron, Mathieu Oriol, François Maccari, Elisa Cinotti, Beatrice Trombert‐Paviot, Bienvenu Bongue, Jean‐Luc Perrot   +10 more
wiley   +1 more source

Atherosclerotic Plaque Crystals Induce Endothelial Dysfunction. [PDF]

Int J Mol Sci
Thazhathveettil J, Gomez SA, Olaoseeji D, Wu R, Sirsjö A, Paramel GV.   +5 more
europepmc   +1 more source

Atherosclerotic plaque instability in symptomatic non-significant carotid stenoses [PDF]

Paul Cyréus, Konrad Wadén, Sandra Hellberg, Otto Bergman, Mariette Lengquist, Eva Karlöf, Andrew J. Buckler, Ljubica Matic, Joy Roy, David Marlevi, Melody Chemaly, Ulf Hedin   +11 more
openalex   +1 more source

Rosuvastatin Upregulates RCOR1 to Repress C10ORF10 Transcription and Alleviate Oxidative Stress and Plaque Formation in Atherosclerosis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Rosuvastatin (RVS) is an HMG‐CoA reductase inhibitor with lipid‐lowering properties. This study aims to investigate the role of RVS in plaque formation in atherosclerosis (AS) and its functional mechanism. ApoE−/− mice were fed a high‐fat diet to generate a mouse model of AS.
Xin Fu, Chuang Liu, Ya‐Li Chen, Jie‐Lin Qin, Ting‐Ting Wang, Shan‐Shan Fu   +5 more
wiley   +1 more source